Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: A report from the Childrens Oncology Group
Pediatric Blood & Cancer, 08/20/2012
Appel BE et al. – This subset analysis demonstrates the chemosensitivity of pediatric lymphocyte–predominant Hodgkin lymphoma (LPHL). Patients who had a complete response to chemotherapy had an excellent EFS and OS without the addition of radiotherapy.